Work

PD-L1 Assay Concordance in Metastatic Renal Cell Carcinoma and Metastatic Urothelial Carcinoma

Year: 2020

Type: article

Study design: Observational Study

Source: Clinical Genitourinary Cancer

DOI: 10.1016/j.clgc.2020.03.020

Authors: Landon C. Brown, Jason Zhu, Matthew K. Labriola, Yuan Wu, Sachica Cheris, Xin Liu, Kathryn Perkinson, Zuowei Su, Shannon McCall, Jiaoti Huang, Wen-Chi Foo, Rajan T. Gupta, Andrew J. Armstrong, Daniel J. George, Michael R. Harrison, Tian Zhang

Institutions: Duke University, Duke Medical Center, Duke Cancer Institute

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Constellation Energy Group, Bristol-Myers Squibb, Pfizer, AstraZeneca, Merck, Novartis, Sanofi, AbbVie, Bayer Corporation, Regeneron Pharmaceuticals, Seattle Genetics, Exelixis, Dendreon Pharmaceuticals, Active Biotech, Genentech, Janssen Biotech

OpenAlex ID: W3015728853

FWCI: 0.08

Cites: 19

Cited by: 3

Related to: 10